EFCCA is funded by its national members that contribute with an annual fee based on their number of registered volunteers.
EFCCA can also be supported by projects in partnership with sponsors whose role is to co-design and co-implement EFCCA initiatives and activities.
EFCCA supports a policy of full transparency regarding its funding sources. If you would like to receive more information about this please get in contact with our office.
Read our Commitment To Transparency
Sponsors in 2024:
AbbVie, Agomab, Boehringer Ingelheim, Bristol Myers Squibb (BMS), Celgene International, CELLTRION, Galapagos, Janssen Immunology Pharmaceutical, Lilly, Pfizer, Sandoz and Takeda
